Worldwide patent portfolio expands to 96
COPPELL, Texas--(BUSINESS WIRE)--Sep. 4, 2014--
Mannatech®,
Incorporated (NASDAQ: MTEX), the
pioneer of nutritional glycobiology and leading innovator of naturally
sourced supplements based on Real
Food Technology® solutions, and creator of the M5MSM (Mission
5 MillionSM) social entrepreneurial
movement, announced the issuance of two new patents in Australia and one
in Japan on product technologies. In total, Mannatech holds 96 patents
worldwide.
One of the issued patents applies to Mannatech’s PhytoMatrix®
formulation (titled All Natural Multivitamin and Multimineral Dietary
Supplement Formulations for Enhanced Absorption and Biological
Utilization). PhytoMatrix caplets are based on Mannatech’s Real Food
Technology solutions, which provide standardized levels of nutrients
sourced from fruits, vegetables and plants.* To date, six patents have
been issued worldwide for the technology pertaining to Mannatech’s
PhytoMatrix formulation.
Two of the patents issued apply to Mannatech’s Ambrotose AO® formulation
(one issued in Australia and another in Japan). Ambrotose AO capsules
provide a blend of plant extracts and antioxidant compounds with
vitamins C and E to help the body combat oxidative stress. Just two
capsules a day are scientifically validated to provide over two and a
half times more antioxidant protection than five servings of fruits and
vegetables.* To date, 31 patents have been issued worldwide to Mannatech
for the technology pertaining to its Ambrotose AO formulation.
“A pillar of Mannatech from the very beginning has been product
innovation,” commented Dr. Robert A. Sinnott, CEO and Chief Science
Officer of Mannatech. “Our robust and ever-expanding patent portfolio
tangibly shows our continued commitment to innovation. Our systematic
approach to research and intellectual property development is a constant
part of our everyday efforts at the company. It serves as a huge asset
to both the company and its thousands of Independent Associates.”
Anyone interested in learning more about Mannatech can visit
Mannatech.com. To review publications, studies and other scientific
information regarding the company’s products, visit MannatechScience.org.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico, Namibia and Hong Kong. For more
information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “believe,” “intend” or other similar words or the
negative of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein are
also considered forward-looking statements. Mannatech believes this
release should be read in conjunction with all of its filings with the
United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain
events, risks, uncertainties and other factors. Some of these factors
include, among others, Mannatech’s inability to attract and retain
Associates and Members, increases in competition, litigation, regulatory
changes and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
*These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Ben Hulet, 972-471-7224
bhulet@mannatech.com